Chlamydia Trachomatis, Gonorrhea
Conditions
Brief summary
This is a randomized controlled trial to determine whether a home screening test for chlamydia and gonorrhea will lead to increased use of screening tests and increased detection of sexually transmitted diseases.
Detailed description
This is a phase III randomized controlled trial. We enrolled 403 young women from a variety of clinical settings and neighborhoods in the Pittsburgh, PA region. Women completed a baseline questionnaire and then were randomized to either an intervention group (receive home testing kit every six months) or to a control group (receive a letter suggesting a clinic visit for screening). Participants were followed for 2 years, and medical chart abstraction was done to document tests done in clinical settings. The final study end points were number of tests completed, number of screening tests completed, number of STDs detected, and incident cases of pelvic inflammatory disease.
Interventions
BEHAVIORALhome testing kit
Sponsors
Agency for Healthcare Research and Quality (AHRQ)
University of Pittsburgh
Study design
Allocation
RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
PREVENTION
Masking
NONE
Eligibility
Sex/Gender
FEMALE
Age
15 Years to 29 Years
Healthy volunteers
Yes
Inclusion criteria
age 15 to 29, 2 or more risk factors for STDs, sexually active -
Exclusion criteria
currently pregnant, homeless \-
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| chlamydia and gonorrhea tests completed | — |
| chlamydia and gonorrhea infections detected | — |
Secondary
| Measure | Time frame |
|---|---|
| pelvic inflammatory disease cases detected | — |
Countries
United States
Outcome results
None listed